Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/18597 
Year of Publication: 
2006
Series/Report no.: 
RWI Discussion Papers No. 46
Publisher: 
Rheinisch-Westfälisches Institut für Wirtschaftsforschung (RWI), Essen
Abstract: 
This paper examines effects of reference pricing for prescription drugs in German social health insurance based on econometric panel data methods. We analyze the effect on ex-factory prices. Moreover, we investigate whether manufacturers adapt prices of their products not subject to reference pricing as a consequence of changes in reference prices of their products subject to reference pricing.We use a large panel data set of nearly all German prescription drugs on a monthly basis between October 1994 and July 2005. Altogether, the data comprise almost 4 million observations. They provide information on ex-factory prices, reference prices, manufacturers, type of prescription drug, and market entries and exits. Our results show that there is no full price adjustment:A 1%-change in reference prices leads to a 0.3%-change in market prices. Price adjustment, however, is fast, it mostly happens in the first month. Furthermore, the first introduction of a reference price reduces market prices of the affected products by approximately 14%. Finally, we observe a significant time effect which is positive in the market without reference prices and negative in that with reference price.
Subjects: 
Price elasticity
temporal development
fixed effects model
JEL: 
I11
I18
Document Type: 
Working Paper

Files in This Item:
File
Size
208.04 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.